
Systematix Corporate (SYSTMTXC) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
1.3B
Gross Profit
770.1M
61.57%
Operating Income
340.6M
27.23%
Net Income
457.6M
36.59%
Balance Sheet Metrics
Total Assets
4.3B
Total Liabilities
1.3B
Shareholders Equity
3.0B
Debt to Equity
0.43
Cash Flow Metrics
Operating Cash Flow
232.8M
Free Cash Flow
-229.0M
Revenue & Profitability Trend
Systematix Corporate Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.3B | 1.2B | 679.4M | 812.0M | 524.4M |
Cost of Goods Sold | 480.6M | 451.5M | 356.5M | 362.7M | 284.3M |
Gross Profit | 770.1M | 703.2M | 323.0M | 449.3M | 240.2M |
Operating Expenses | 397.7M | 189.8M | 166.2M | 197.7M | 143.7M |
Operating Income | 340.6M | 408.4M | 61.3M | 170.6M | 22.0M |
Pre-tax Income | 570.9M | 677.3M | 57.6M | 233.6M | 10.7M |
Income Tax | 113.3M | 143.8M | 6.8M | 58.6M | -2.5M |
Net Income | 457.6M | 533.5M | 50.8M | 175.0M | 13.2M |
EPS (Diluted) | - | ₹4.11 | ₹0.39 | ₹1.35 | ₹0.10 |
Income Statement Trend
Systematix Corporate Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 3.1B | 2.5B | 1.5B | 1.9B | 1.6B |
Non-Current Assets | 1.2B | 590.3M | 318.0M | 327.1M | 129.2M |
Total Assets | 4.3B | 3.1B | 1.8B | 2.3B | 1.7B |
Liabilities | |||||
Current Liabilities | 920.8M | 1.2B | 600.0M | 1.1B | 558.0M |
Non-Current Liabilities | 364.0M | 320.4M | 221.8M | 227.0M | 380.5M |
Total Liabilities | 1.3B | 1.6B | 821.9M | 1.3B | 938.5M |
Equity | |||||
Total Shareholders Equity | 3.0B | 1.5B | 990.9M | 949.9M | 771.4M |
Balance Sheet Composition
Systematix Corporate Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 570.9M | 677.3M | 57.6M | 233.6M | 10.7M |
Operating Cash Flow | 232.8M | 575.4M | 230.4M | 145.4M | -72.1M |
Investing Activities | |||||
Capital Expenditures | -27.7M | -125.8M | -1.6M | -7.1M | -1.4M |
Investing Cash Flow | -27.7M | -125.8M | 6.2M | -154.0M | -20.6M |
Financing Activities | |||||
Dividends Paid | -13.0M | - | -13.0M | - | - |
Financing Cash Flow | 1.0B | - | -13.0M | - | 3.0M |
Free Cash Flow | -229.0M | 752.4M | -155.7M | 498.7M | 177.0M |
Cash Flow Trend
Systematix Corporate Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.32
Price to Book
4.81
Price to Sales
10.59
Profitability Ratios
Profit Margin
33.84%
Operating Margin
12.41%
Return on Equity
20.24%
Return on Assets
12.42%
Financial Health
Current Ratio
3.39
Debt to Equity
6.76
Beta
0.72
Per Share Data
EPS (TTM)
₹3.46
Book Value per Share
₹21.82
Revenue per Share
₹10.22
Financial data is updated regularly. All figures are in the company's reporting currency.